Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal Dexmedetomidine for Perioperative Anxiety in Colorectal Cancer
NCT06139926Phase 3Recruiting
- Sponsor
- First Affiliated Hospital of Chongqing Medical University
- Start
- Dec 2023
- Primary completion
- Jun 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of dexmedetomidine in anxiety disorder, major depressive disorder (MDD), sponsored by First Affiliated Hospital of Chongqing Medical University. Started Dec 2023; status: recruiting.
02
Drugs
dexmedetomidine
03
Conditions
anxiety disordermajor depressive disorder (MDD)
Beyond the preview
Go deeper on NCT06139926.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06139926.